Age-Independent Cardiac Protection by Pharmacological Activation of Beclin-1 During Endotoxemia and Its Association

Matthew Kim1, Azadeh Nikouee1, Raymond Zou2

  • 1Department of Surgery, Burn & Shock Trauma Research Institute Loyola University Chicago Stritch School of Medicine Maywood IL.

Insights

TB-peptide activates autophagy to protect the heart during endotoxemia in young and aged mice. This peptide improves cardiac function and metabolism, offering therapeutic potential for sepsis-induced cardiomyopathy.

Area of Science:

  • Cardiovascular Science
  • Autophagy Research
  • Metabolomics

Background:

  • Beclin-1-dependent autophagy protects the heart during endotoxemia.
  • The therapeutic potential of Beclin-1 activating peptide (TB-peptide) in endotoxemia needs further investigation, particularly in aged populations.
  • Lipopolysaccharide (LPS) challenge induces cardiac dysfunction and metabolic alterations.

Purpose of the Study:

  • To compare the therapeutic effects of TB-peptide on endotoxemia-induced cardiac outcomes in young adult and aged mice.
  • To evaluate LPS-induced and TB-peptide treatment-mediated alterations in myocardial metabolism.
  • To assess the impact of TB-peptide on autophagy and cytokine levels.

Main Methods:

  • Young (10-week) and aged (24-month) C57BL/6J mice were challenged with LPS.
  • Mice received TB-peptide or vehicle treatment.
  • Cardiac function, circulating cytokines, myocardial autophagy, and myocardial metabolites (361 targeted) were evaluated.

Main Results:

  • TB-peptide enhanced autophagy, reduced cytokines, and improved cardiac performance in both young and aged mice during endotoxemia.
  • LPS impaired glucose and amino acid metabolism, which TB-peptide ameliorated in all age groups.
  • Lipid metabolism showed age-dependent responses to LPS, with TB-peptide partially mitigating effects in young mice but not aged mice.

Conclusions:

  • Pharmacological Beclin-1 activation via TB-peptide offers cardiac protection during endotoxemia in both young and aged individuals.
  • TB-peptide demonstrates therapeutic potential for sepsis-induced cardiomyopathy.
  • Age-independent protection by TB-peptide is linked to the reprogramming of energy production through glucose and amino acid metabolism.

Related Concept Videos